ClinicalTrials.gg
Not yet recruitingNCT07421505Updated Feb 19, 2026

Spinal Mobility in Children With Cerebral Palsy: NDT-Bobath and Exergaming

An interventional study of NDT-Bobath Therapy and Sitting Exergaming in Spastic Diplegia Cerebral Palsy and Spastic Hemiplegia, sponsored by Wroclaw University of Health and Sport Sciences. Not yet recruiting at 2 sites in Poland. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-02-19.

Sponsored by Wroclaw University of Health and Sport Sciences · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
6 Years to 18 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate changes in spinal mobility in the cervical, thoracic, and lumbar regions in children with cerebral palsy aged 10-15 years. The study will compare outcomes between standard NDT-Bobath therapy supplemented with exergaming in a sitting position and exergaming in a standing position. Postural stability, body composition, and functional parameters will also be assessed.

Participants will complete a socio-medical questionnaire and undergo baseline measurements of spinal mobility, cervical range of motion, postural stability (using Podoscan and Zebris platform), body height, and body composition (using SECA stadiometer and Tanita bioimpedance analyzer).

The intervention will last 3 months and include twice-weekly 60-minute therapy sessions. Group I will receive NDT-Bobath therapy supplemented with exergaming in a sitting position, while Group II will receive NDT-Bobath therapy with exergaming in a standing position.

After the intervention, participants will undergo post-intervention measurements and a follow-up evaluation three months later to assess the persistence of any changes.

Read the detailed description

This study aims to evaluate the effects of NDT-Bobath therapy supplemented with exergaming on spinal mobility in children with cerebral palsy (CP) aged 10-15 years. Based on these calculations, a representative study sample includes 42 participants.

Eligible participants are children diagnosed by a physician with spastic diplegia (G80.1) or spastic hemiplegia (G80.2), the two most common clinical phenotypes of CP, representing approximately 35% and 25% of cases, respectively. Participants will be randomly assigned to two intervention groups:

Group I: NDT-Bobath therapy supplemented with exergaming performed in a sitting position.

Group II: NDT-Bobath therapy supplemented with exergaming performed in a standing position.

Participants' data will only be included in the final analysis if their attendance at therapy sessions is at least 85%.

The study will be conducted in four stages:

Stage I - Pilot Study:

A pilot study with 15 participants (who will not participate in the main study) will determine the optimal duration for measuring center-of-pressure sway in children aged 10-15 with CP. Postural stability will be assessed using posturography, Podoscan, and the Zebris platform. Zebris measurements will be dynamic and last 30, 60, and 90 seconds. Baseline assessments will include:

Socio-medical questionnaire covering personal, medical, physiotherapy, educational data, orthopedic equipment usage, physical and therapeutic activities, and nutrition.

Lumbar and thoracic spinal mobility in sagittal and transverse planes and kinematic chain mobility (lumbar spine, pelvic girdle, and lower limbs) using the MyoMotion system.

Cervical spine active range of motion using the CROM device in sagittal, frontal, and horizontal planes.

Body height via SECA 213 stadiometer and body composition (general and segmental fat mass, lean mass, estimated muscle mass) via Tanita bioimpedance analyzer.

Stage II - Intervention:

The intervention program will last 3 months, with 60-minute sessions twice weekly at a collaborating rehabilitation center.

Group I (sitting exergaming): NDT-Bobath therapy with exercises for muscle tone normalization in the pelvic girdle, central stability enhancement including trunk rotation, and exercises for shoulder girdle tone normalization. Therapy sessions follow three core NDT principles: facilitation, stimulation, and communication. Exergaming will be performed in a seated position with hips, knees, and ankles at 90°, allowing gradual position changes between exercises to manage child concentration.

Group II (standing exergaming): NDT-Bobath therapy with similar exercises as Group I, but exergaming performed in a standing position with appropriate posture. Session structure includes adjustments for position changes and attention management.

Participants will be classified according to compensatory patterns:

Type A/A: symmetrical antigravity pattern

Type P/P: symmetrical progravity pattern

Type A/P: mixed antigravity/progravity pattern

Exergaming will use Kinect Therapy-Based Exergames with Microsoft Kinect.

Stage III - Post-intervention Assessment:

Spinal mobility (lumbar, thoracic, cervical) will be reassessed using the same instruments as in Stage I.

Stage IV - Follow-up:

A repeat assessment identical to Stage III will be conducted 3 months after the intervention to evaluate the persistence of therapeutic effects.

02

Conditions studied

  • Spastic Diplegia Cerebral Palsy
  • Spastic Hemiplegia

Keywords

  • Cerebral palsy
  • Spinal mobility
  • NDT-Bobath therapy
  • Exergaming
03

In context

Cerebral palsy, spastic, diplegic

27 studies on the registry are indexed under Cerebral palsy, spastic, diplegic; 7 are open to participants now.

This study's planned enrollment of 42 is close to the median of 42 across 23 interventional studies indexed under Cerebral palsy, spastic, diplegic.

Browse Cerebral palsy, spastic, diplegic studies →

Lead sponsor

Wroclaw University of Health and Sport Sciences is the lead sponsor of 47 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Written from parents/guardians and the child (if capable)
  • GMFCS levels I-III (mild to moderate motor limitations)
  • Ability to maintain standing position
  • Ability to follow instructions and perform exercises
  • No prior exergaming therapy
  • No implanted electronic devices
  • No acute infections or inflammatory conditions
  • No metabolic disorders affecting bioimpedance measurements

Exclusion criteria

Exclusion Criteria:

  • GMFCS levels IV-V
  • Orthopedic surgery within the past 12 months
  • Seizure episodes within the past 6 months
  • Cognitive or behavioral impairments preventing cooperation
  • Severe spinal deformities (scoliosis >40° or other significant changes)
  • Attendance at therapy sessions \<85%
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
42 participants (estimated)

Study arms

  • Experimental
    NDT-Bobath + Sitting Exergaming

    Participants in this group will receive standard NDT-Bobath therapy supplemented with exergaming performed in a seated position. Therapy sessions will last 60 minutes, twice weekly, for 3 months. The NDT-Bobath component focuses on: Normalizing muscle tone in the pelvic and shoulder girdle Enhancing central trunk stability, including trunk rotation Promoting symmetrical posture and controlled movement according to NDT principles (facilitation, stimulation, communication) The exergaming component will be performed while seated on a chair with adjustable height to achieve 90° flexion at hips, knees, and ankles. Exercises will engage three-dimensional trunk and limb movements, be visually engaging, and allow personalization according to each child's functional level. Exercises are safe, non-impact, and synchronized with the MyoMotion system for monitoring.

    Other: NDT-Bobath Therapy · Other: Sitting Exergaming

  • Experimental
    NDT-Bobath + Standing Exergaming

    Participants in this group will receive standard NDT-Bobath therapy supplemented with exergaming performed in a standing position. Therapy sessions will last 60 minutes, twice weekly, for 3 months. The NDT-Bobath component focuses on: Normalizing muscle tone in the pelvic and shoulder girdle Enhancing central trunk stability, including trunk rotation Promoting symmetrical posture and controlled movement according to NDT principles (facilitation, stimulation, communication) The exergaming component will be performed in a standing position, promoting weight-bearing and functional trunk and limb control. Exercises engage three-dimensional movements, are visually appealing, and personalized according to the child's functional abilities. Exercise intensity is safe and designed to prevent injury, with position adjustments between exercises as needed. Exercises are synchronized with the MyoMotion system for real-time monitoring.

    Other: NDT-Bobath Therapy · Other: Standing Exergaming

Interventions

  • OtherNDT-Bobath Therapy

    Standard NDT-Bobath neurodevelopmental therapy focusing on normalization of muscle tone in the pelvic and shoulder girdle, enhancement of central trunk stability including rotational control, and promotion of symmetrical posture and controlled movements according to NDT principles (facilitation, stimulation, communication). Dosage - 60-minute sessions, twice weekly, for 3 months.

    Also known as: Neurodevelopmental Treatment (Bobath Concept)

  • OtherSitting Exergaming

    Exergaming performed in a seated position using Kinect Therapy-Based Exergames. Participants sit on an adjustable chair with hips, knees, and ankles flexed at 90°. Exercises involve safe, non-impact, visually engaging three-dimensional trunk and limb movements, personalized to the child's functional level. Movements are synchronized with the MyoMotion system for monitoring. Dosage - 60-minute sessions, twice weekly, for 3 months (as part of combined therapy).

    Also known as: Seated Exergaming

  • OtherStanding Exergaming

    Exergaming performed in a standing position using Kinect Therapy-Based Exergames, promoting weight-bearing and functional trunk and limb control. Exercises involve safe, visually engaging three-dimensional movements, personalized to the child's functional abilities. Movements are synchronized with the MyoMotion system for real-time monitoring. Dosage - 60-minute sessions, twice weekly, for 3 months (as part of combined therapy).

06

What researchers measure

Primary outcomes

  1. Cervical Spine Mobility

    Change in active cervical spine range of motion in children with cerebral palsy aged 10-15 years, measured in sagittal, frontal, and transverse planes using the CROM device. Cervical flexion/extension, lateral flexion, and rotation are expressed in degrees.

    Time frame: Baseline, post-intervention (3 months), follow-up (6 months)

  2. Thoracic Spine Mobility

    Change in thoracic spine mobility measured as active range of motion and trunk rotation using the MyoMotion system. Measurements are expressed in degrees and reflect thoracic flexion/extension, lateral flexion, and rotational movements.

    Time frame: Baseline, post-intervention (3 months), follow-up (6 months)

  3. Lumbar Spine Mobility

    Change in lumbar spine mobility measured as active range of motion using the MyoMotion system. Lumbar flexion/extension, lateral flexion, and rotation are expressed in degrees.

    Time frame: Baseline, post-intervention (3 months), follow-up (6 months)

07

Study locations

2 sites
  • Specjalistyczne Centrum Medyczne im. Jana Pawła II S.A.
    Polanica-Zdrój, Lower Silesian Voivodeship 57-320, Poland
    • Aleksandra Kopaczyńska, Master of Science · Contactaleksandra.kopaczynska@awf.wroc.pl · +48601157773
    • Aleksandra Kopaczyńska, Master of Science · Principal investigator
  • Wroclaw University of Health and Sport Sciences
    Wroclaw, Lower Silesian Voivodeship 51-612, Poland
    • Aleksandra Kopaczyńska, Master of Science · Contactaleksandra.kopaczynska@awf.wroc.pl · +48601157773
    • Aleksandra Kopaczyńska, Master of Science · Principal investigator
08

References and documents

Individual participant data

Plan to share: Undecided — At this time, a final decision has not been made regarding the sharing of de-identified individual participant data (IPD). Potentially shareable data would include de-identified demographic information and outcome data relevant to the primary and secondary endpoints of the study. The decision regarding IPD sharing will be made after completion of the study and final data analyses. This is due to the need to evaluate: compliance with applicable data protection and privacy regulations, limitations related to the informed consent obtained from participants, potential contractual or institutional obligations, the risk of participant re-identification despite data de-identification. Following study completion and publication of results, the possibility of sharing IPD will be reconsidered.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Feb 2026; primary completion for Jun 2026, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 28, 2026
First posted
Feb 19, 2026
StartEst.
Feb 2026
Primary completionEst.
Jun 2026
CompletionEst.
Jun 2026
Last update
Feb 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07421505
Lead sponsor
Wroclaw University of Health and Sport Sciences
Responsible party
Aleksandra Kopaczyńska (Principal Investigator, Wroclaw University of Health and Sport Sciences) — Principal investigator
First posted
Feb 19, 2026
Start date
Feb 2026 (estimated)
Primary completion
Jun 2026 (estimated)
Completion
Jun 2026 (estimated)
Last update
Feb 19, 2026

Study contacts

Aleksandra Kopaczyńska, Master of Science
Contact
aleksandra.kopaczynska@awf.wroc.pl
+48601157773

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion